2023-08-14 16:07:02 ET
More on Heron Therapeutics
- Heron Therapeutics: Restructuring Brings About A New Dawn
- Heron Therapeutics: Look For Continued Limbo Stick Dancing - Extreme Investor Caution Merited
- Heron Therapeutics Q2 2023 Earnings Preview
- Heron Therapeutics rises on layoffs, ~$30M private placement financing
- Heron stock slumps ~35% amid quarterly misses on both lines
- Heron stock falls ~10% as headwinds for Zynrelef label, device delivery linger
- Seeking Alpha’s Quant Rating on Heron Therapeutics
- Earnings data for Heron Therapeutics
For further details see:
Heron Therapeutics GAAP EPS of -$0.35 misses by $0.12, revenue of $31.76M beats by $0.06M